Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 4, 2010, Pages 719-720

  Park, Young Min ^a   Jung, Yeon Kyung ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INFUSION FLUID; LITHIUM; LORAZEPAM; METHYLPHENIDATE; PAROXETINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; CASE REPORT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HUMAN; LETTER; MAJOR DEPRESSION; MALE; MANIA; PATIENT COMPLIANCE; PSYCHOSIS; REMISSION; SEROTONIN SYNDROME; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; VITAL SIGN;

ADOLESCENT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; HUMANS; MALE; METHYLPHENIDATE; PAROXETINE; SEROTONIN SYNDROME; TREATMENT OUTCOME;

EID: 77952672787     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.03.016     Document Type: Letter

References (14)

1. Attar-Herzberg D., Apel A., Gang N., Dvir D., Mayan H. The serotonin syndrome: initial misdiagnosis. Isr Med Assoc J 2009, 11:367-370.
2. Boyer E.W., Shannon M. The serotonin syndrome. N Engl J Med 2005, 352:1112-1120.
3. Gatley S.J., Pan D., Chen R., Chaturvedi G., Ding Y.S. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 1996, 58:231-239.
4. Isbister G.K., Whyte I.M. Serotonin toxicity and malignant hyperthermia: role of 5-HT2 receptors. Br J Anaesth 2002, 88:603.
5. Ishii M., Tatsuzawa Y., Yoshino A., Nomura S. Serotonin syndrome induced by augmentation of SSRI with methylphenidate. Psychiatry Clin Neurosci 2008, 62:246.
6. John A.P., Koloth R. Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine. Aust N Z J Psychiatry 2007, 41:192-193.
7. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997, 68:2032-2037.
8. Lavretsky H., Kim M.D., Kumar A., Reynolds C.F. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. J Clin Psychiatry 2003, 64:1410-1414.
9. Liau C.H., Shen W.W., Su K.P. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient. Psychiatry Clin Neurosci 2006, 60:121-122.
10. Liberek C., Aubry J.M., Baud P. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association. Therapie 2006, 61:531-533.
11. Markowitz J.S., DeVane C.L., Pestreich L.K., Patrick K.S., Muniz R. A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol 2006, 16:687-698.
12. Martin T.G. Serotonin syndrome. Ann Emerg Med 1996, 28:520-526.
13. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
14. Wingo A.P., Ghaemi S.N. Frequency of stimulant treatment and of stimulant-associated mania/hypomania in bipolar disorder patients. Psychopharmacol Bull 2008, 41:37-47.